Raising new questions on best care for bronchiectasis

Affiliations

Comment

Brian O'Sullivan. Lancet Respir Med. 2019 Oct.

. 2019 Oct;7(10):828-829.

doi: 10.1016/S2213-2600(19)30181-X. Epub 2019 Aug 9.

¹ Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA. Electronic address: osullivb@hitchcock.org.

No abstract available

Comment on

The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis.
Laska IF, Crichton ML, Shoemark A, Chalmers JD. Laska IF, et al. Lancet Respir Med. 2019 Oct;7(10):855-869. doi: 10.1016/S2213-2600(19)30185-7. Epub 2019 Aug 9. Lancet Respir Med. 2019. PMID: 31405826
Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
Chalmers JD, Boersma W, Lonergan M, Jayaram L, Crichton ML, Karalus N, Taylor SL, Martin ML, Burr LD, Wong C, Altenburg J. Chalmers JD, et al. Lancet Respir Med. 2019 Oct;7(10):845-854. doi: 10.1016/S2213-2600(19)30191-2. Epub 2019 Aug 9. Lancet Respir Med. 2019. PMID: 31405828